AGREEMENT AND PLAN OF MERGER by and among NOVARTIS CORPORATION ZODNAS ACQUISITION CORP. an indirect, wholly owned subsidiary of Novartis Corporation EON LABS, INC. and for purposes of Section 10.12 only, NOVARTIS AG Dated as of February 20, 2005Merger Agreement • January 30th, 2006 • Novartis Ag • Pharmaceutical preparations • Delaware
This Agreement and Plan of Merger (this “Agreement”) is made and entered into as of this 20th day of February 2005, by and among Novartis Corporation, a New York corporation (“Novartis”), Zodnas Acquisition Corp., an indirect, wholly owned Subsidiary of Novartis (“Merger Sub”), Eon Labs, Inc., a Delaware corporation (the “Company”) and, for purposes of Section 10.12 only, Novartis AG, a Swiss Company (“Parent”).
Employment ContractEmployment Contract • January 30th, 2006 • Novartis Ag • Pharmaceutical preparations
Your Employment Contract consists of the employment conditions as set forth in this contract and the internal rules and regulations (attached or referred to herein), which constitute an integral part of this Contract.
AGREEMENT FOR PURCHASE AND SALE OF STOCK OF EON LABS, INC. by and between NOVARTIS CORPORATION, as PURCHASER, SANTO HOLDING (DEUTSCHLAND) GMBH, as SELLER, AND, FOR THE PURPOSES OF SECTION 12 ONLY, NOVARTIS AG Dated as of February 20, 2005Purchase and Sale Agreement • January 30th, 2006 • Novartis Ag • Pharmaceutical preparations
Novartis Corporation, a company organized under the laws of the State of New York (“Purchaser”) with its principal office located at 608 Fifth Avenue, New York, NY 10020 USA;
Novartis AGDeposit Agreement • January 30th, 2006 • Novartis Ag • Pharmaceutical preparations
AGREEMENT AND PLAN OF MERGER by and among NOVARTIS CORPORATION, NOVARTIS BIOTECH PARTNERSHIP, INC.,Agreement and Plan of Merger • January 30th, 2006 • Novartis Ag • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of October 30, 2005, by and among Novartis Corporation, a New York corporation (“Novartis”) and an indirect wholly owned subsidiary of Novartis AG, a stock corporation organized under the laws of Switzerland (“Parent”), Novartis Biotech Partnership, Inc., a Delaware corporation and a subsidiary of Novartis (“Merger Sub”), Chiron Corporation, a Delaware corporation (the “Company”), and, for purposes of Section 10.14 only, Parent.
